Study Phase
3
Topiramate Clinical Trial in Primary Generalized Tonic-Clonic Seizures
Data Specification
Not Available
Annotated CRF
Not Available
Trial Information
Generic Name
Topiramate
Product Name
TOPAMAX®
Therapeutic Area
Nervous System Diseases
Enrollment
80
% Female
43.7%
% White
85.0%
Product Class
Anticonvulsants
Sponsor Protocol Number
YTC
Data Partner
Johnson & Johnson
Condition Studied
Epilepsy
Mean/Median Age (Years)
26.2
Supporting Documentation
Clinical Study Report
Collected Datasets
APPROVED DATA REQUESTS ASSOCIATED WITH THIS TRIAL
Disclaimer
Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.